This dual mode of action, both genomic and non-genomic, highlights the complex interplay between BPA and estrogen receptor signaling, ultimately leading to GOLPH3 upregulation and contributing to the tumorigenic potential of colon cancer cells. Here, GOLPH3 is linked to colonic neoplasm.